Vertex Pharmaceuticals Incorporated
INHIBITORS OF APOL1 AND METHODS OF USING SAME

Abstract:

The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomeulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).